Scholarlink

<p>Although preventive vaccine is available, HBV infection continues to be a global health challenge, especially in rapid and accurate screening in resource-limited regions due to underdeveloped infrastructures. In this study, we developed a self-powered DNA walker system integrating AuNPs and DNAzyme for direct detection of HBV DNA in blood. In the presence of HBV DNA, this DNA walker was activated to start autonomous and rapid movement on AuNPs driven by DNAzyme, and the amplified fluorescent signals were generated and detected. With remarkable specificity and biostability, this DNA walker system was validated by detecting HBV DNA in blood samples from patients chronically infected with HBV. Our results demonstrated that the HBV DNA load of 20,000&#xa0;IU/mL in plasma could be detected by our strategy, and there was a strong correlation (Pearson’s <i>r</i> = -0.86) between the fluorescence intensity measured by the DNA walker and the Ct value. Collectively, we established a simple, efficient, and rapid detection strategy for HBV DNA in the blood, with substantial potential application in resource-limited countries/regions.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A robust DNA walker for simplified, rapid, and sensitive detection of HBV DNA in blood

  • 期刊论文

  • 发表日期：

    2025年6月13日

查看全文
  • Rongji Lai,
  • Mingshuang Lai,
  • Baoren He,
  • Bin Li,
  • Linbin Huang,
  • He Xie,
  • Limin Chen

摘要

Although preventive vaccine is available, HBV infection continues to be a global health challenge, especially in rapid and accurate screening in resource-limited regions due to underdeveloped infrastructures. In this study, we developed a self-powered DNA walker system integrating AuNPs and DNAzyme for direct detection of HBV DNA in blood. In the presence of HBV DNA, this DNA walker was activated to start autonomous and rapid movement on AuNPs driven by DNAzyme, and the amplified fluorescent signals were generated and detected. With remarkable specificity and biostability, this DNA walker system was validated by detecting HBV DNA in blood samples from patients chronically infected with HBV. Our results demonstrated that the HBV DNA load of 20,000 IU/mL in plasma could be detected by our strategy, and there was a strong correlation (Pearson’s r = -0.86) between the fluorescence intensity measured by the DNA walker and the Ct value. Collectively, we established a simple, efficient, and rapid detection strategy for HBV DNA in the blood, with substantial potential application in resource-limited countries/regions.

Graphical Abstract